NCT05422651 Observational Study About In-patients Admitted With Fever
| NCT ID | NCT05422651 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xiangya Hospital of Central South University |
| Condition | Fever |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2024-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-06-01 with a primary completion date of 2024-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fever is a common symptom in patients with infectious diseases. This study hopes to understand the epidemiological characteristics of patients hospitalized due to fever through observational research, including: clinical characteristics, etiology of fever and prognosis after treatment. So as to further search for biochemical or other serological indicators to predict the diagnosis and prognosis of infectious fever and non-infectious fever, and try to establish relevant prediction models.
Eligibility Criteria
Inclusion Criteria: * all patients admitted to department of infectious diseases because of fever Exclusion Criteria: * patents who refuse to sign informed consent
Contact & Investigator
Yan Huang
PRINCIPAL INVESTIGATOR
Xiangya Hospital of Central South University
Frequently Asked Questions
Who can join the NCT05422651 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 90 Years, studying Fever. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05422651 currently recruiting?
Yes, NCT05422651 is actively recruiting participants. Contact the research team at drhyan@163.com for enrollment information.
Where is the NCT05422651 trial being conducted?
This trial is being conducted at Changsha, China.
Who is sponsoring the NCT05422651 clinical trial?
NCT05422651 is sponsored by Xiangya Hospital of Central South University. The principal investigator is Yan Huang at Xiangya Hospital of Central South University. The trial plans to enroll 500 participants.